Andolast

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAndolast
Drug Alias Name安多司特AndolastumDiazolastCR-2039
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium-activated potassium channel openers
TargetsNot applicable
Therapy Area/IndicationsRhinitis, AllergicPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesRottapharm
China Registration ClassN/A

Develop Information

Active CompaniesRottapharm
Inactive CompaniesN/A
Active IndicationsRhinitis, AllergicPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A